Detection of intracellular HIV in lymphocytes by flow cytometry.

Various permeabilization procedures and defined gating techniques were tested in order to optimize existing flow cytometric assays and devise a specific assay for the direct detection of intracellular HIV-1 antigens in clinical blood specimens. In our optimal procedure, blood lysed with Orthomune Lysing Reagent was fixed with 3.7% formaldehyde for 10 min at room temperature and then permeabilized with 0.2% Tween 20 for 15 min at room temperature. Cells from whole blood were labeled with either FITC-anti-p18 or FITC-anti-p24 monoclonal antibodies and PE-anti-Leu M9 (CD33) in order to exclude monocytes and granulocytes from the lymphocyte gate. The assay demonstrated that mean percentages of HIV p24 antigen positive cells were increased in patients with advanced disease. The assay in its present form is useful for monitoring disease progression and for monitoring the effects of antiviral therapy in individuals, but it is not currently sensitive enough to detect consistently the low levels of HIV infected peripheral blood cells in asymptomatic individuals.

[1]  L. Mcbride,et al.  Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. , 1993, Science.

[2]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[3]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.

[4]  S. J. Clark,et al.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.

[5]  F. Chiodo,et al.  Detection of circulating p24 antigen‐positive CD4+ cells during HIV infection by flow cytometry , 1992, AIDS.

[6]  C. Fox,et al.  The pathobiology of HIV infection. , 1992, Immunology today.

[7]  O. Bagasra,et al.  Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. , 1992, The New England journal of medicine.

[8]  K. Fife,et al.  Incidence of HIV infection in monocyte subpopulations characterized by CD4 and HLA‐DR surface density , 1992, AIDS.

[9]  B. Cullen,et al.  Molecular basis of latency in pathogenic human viruses. , 1991, Science.

[10]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[11]  N. Jewell,et al.  Female-to-Male Transmission of Human Immunodeficiency Virus , 1991 .

[12]  TA Kion,et al.  Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice , 1991, Science.

[13]  T. Coates,et al.  Changes in Sexual Practices Over 5 Years of Follow‐Up Among Heterosexual Men in San Francisco , 1991, Journal of acquired immune deficiency syndromes.

[14]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[15]  S. J. Clark,et al.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.

[16]  A. Fauci,et al.  Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. , 1991, AIDS research and human retroviruses.

[17]  Christine A. Lee,et al.  Serial CD4 lymphocyte counts and development of AIDS , 1991, The Lancet.

[18]  W. Greene,et al.  The molecular biology of human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[19]  P. Tomasulo,et al.  Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group. , 1990, The New England journal of medicine.

[20]  F. Rapp,et al.  Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection. , 1990, The Journal of infectious diseases.

[21]  M. Stevenson,et al.  Integration is not necessary for expression of human immunodeficiency virus type 1 protein products , 1990, Journal of virology.

[22]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[23]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[24]  R. Echols,et al.  Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry , 1990, Journal of clinical microbiology.

[25]  P. Simmonds,et al.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers , 1990, Journal of virology.

[26]  J M Taylor,et al.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.

[27]  D. Ho,et al.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.

[28]  A. Collier,et al.  Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[29]  H. Klein,et al.  Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. , 1989, The New England journal of medicine.

[30]  P D Cumming,et al.  Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative. , 1989, The New England journal of medicine.

[31]  C H Fox,et al.  The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.

[32]  D. Ho,et al.  Markers of HIV infection prior to IgG antibody seropositivity. , 1989, JAMA.

[33]  J. Justement,et al.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Fauci,et al.  Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.

[35]  I. Slaper-Cortenbach,et al.  Flow-cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias , 1988 .

[36]  H. Reesink,et al.  Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIV. , 1988, The New England journal of medicine.

[37]  R. Chaisson,et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort , 1988, British medical journal.

[38]  K. Steimer,et al.  In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures. , 1987, American journal of clinical pathology.

[39]  M. Leuther,et al.  Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance. , 1987, The New England journal of medicine.

[40]  J. Goudsmit,et al.  Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. , 1987, British medical journal.

[41]  Y. Cao,et al.  Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. , 1987, Blood.

[42]  J. Levy,et al.  Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study. , 1987, JAMA.

[43]  J. Levy,et al.  Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. , 1987, JAMA.

[44]  J F Leary,et al.  Rare-event analysis methods for detection of fetal red blood cells in maternal blood. , 1984, Cytometry.

[45]  A. Fauci,et al.  Immunopathogenesis of HIV infection. , 1996, Annual review of microbiology.

[46]  D. Katzenstein,et al.  Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration. , 1992, Journal of acquired immune deficiency syndromes.

[47]  G. Brugal,et al.  Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment. , 1991, Cytometry.

[48]  J. Giorgi,et al.  A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. , 1991, Cytometry.

[49]  F. Lacombe,et al.  Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. , 1991, Cytometry.

[50]  M. Favre,et al.  Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry , 1991 .